Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Small Cell Carcinomas of Non-lung Origin”

14 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 14 results

Testing effectiveness (Phase 2)Ended earlyNCT03094169
What this trial is testing

AVID100 in Advanced Epithelial Carcinomas

Who this might be right for
Solid Tumor, AdultTriple Negative Breast CancerHead and Neck Squamous Cell Carcinoma+1 more
Formation Biologics 49
Not applicableLooking for participantsNCT06272864
What this trial is testing

BostonGene and Exigent Genomic INsight Study

Who this might be right for
Breast CancerNon-small Cell Lung CancerMelanoma+1 more
BostonGene 400
Early research (Phase 1)Looking for participantsNCT07517198
What this trial is testing

Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors

Who this might be right for
Solid TumorSmall Cell Lung Cancer (SCLC)High Grade Neuroendocrine Cancer+9 more
Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. 40
Testing effectiveness (Phase 2)Looking for participantsNCT05281406
What this trial is testing

Additional Chemotherapy for EGFRm Patients with the Continued Presence of Plasma CtDNA EGFRm At Week 3 After Start of Osimertinib 1st-line Treatment (PACE-LUNG)

Who this might be right for
NSCLC Stage IIIBNSCLC Stage IV
Goethe University 50
Testing effectiveness (Phase 2)Looking for participantsNCT05696782
What this trial is testing

Quick Start Durvalumab Following Chemoradiation for Stage III Nonsmall Cell Lung Cancer

Who this might be right for
Nonsmall Cell Lung Cancer Stage IIIUnresectable Non-Small Cell Lung CarcinomaNonsmall Cell Lung Cancer, Stage II
Wake Forest University Health Sciences 28
Large-scale testing (Phase 3)Study completedNCT00409188
What this trial is testing

Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer (START)

Who this might be right for
Non-small Cell Lung Cancer
EMD Serono 1,513
Early research (Phase 1)Study completedNCT00037817
What this trial is testing

Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural Malignancies

Who this might be right for
Advanced Esophageal CancersPrimary Small Cell Lung CancersNon-Small-Cell Lung Carcinoma+2 more
National Cancer Institute (NCI) 34
Early research (Phase 1)Looking for participantsNCT05492682
What this trial is testing

START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer

Who this might be right for
Melanoma (Skin)Triple-Negative Breast CancerNon-Small Cell Lung Cancer+5 more
Valo Therapeutics Oy 15
Not applicableStudy completedNCT01537991
What this trial is testing

ISoToxic Accelerated RadioTherapy in Locally Advanced Non-small Cell Lung Cancer: The Phase I/II I-START Trial

Who this might be right for
Locally Advanced Non-small Cell Lung Cancer
Lisette Nixon 81
Not applicableStudy completedNCT06495008
What this trial is testing

Taste and Smell Dysfunction in Patients More Than Two Years After Start of Immune Checkpoint Inhibitor Therapy

Who this might be right for
MelanomaNon-small Cell Lung Cancer (NSCLC)Urogenital Cancers
University Medical Center Groningen 101
Testing effectiveness (Phase 2)Study completedNCT01177397
What this trial is testing

Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma

Who this might be right for
Multiple MyelomaDiffuse Large B-Cell LymphomaGlioblastoma Multiforme+4 more
Celgene 226
Large-scale testing (Phase 3)Study completedNCT00136864
What this trial is testing

Positron Emission Tomography (PET) Imaging in Stage III Non-small Cell Lung Cancer (PET START Trial)

Who this might be right for
Non-Small-Cell Lung Carcinoma
Ontario Clinical Oncology Group (OCOG) 310
Large-scale testing (Phase 3)Looking for participantsNCT05317858
What this trial is testing

Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets

Who this might be right for
Brain TumorNon Small Cell Lung Cancer
InSightec 30
Not applicableUnknownNCT04789252
What this trial is testing

Heterogeneity of Dendritic Cells in Colon and Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
University of Milano Bicocca 64